Relevant bibliographies by topics / Cancer incidence

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Cancer incidence'

Author: Grafiati
Published: 4 June 2021
Last updated: 23 February 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Cancer incidence.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Cancer incidence"

1

Garrepalli, Saritha. "Global Patterns of Lung Cancer Incidence." Cancer Research and Cellular Therapeutics 2, no. 2 (August 1, 2018): 01–03. http://dx.doi.org/10.31579/2640-1053/027.

Full text
Abstract:
Introduction It is well known that smoking is injurious to health which causes lung cancer. Although not all smokers develop lung cancer, fraction of lifelong non-smokers will die from lung cancer. Lung cancer is a major cause of cancer related death in developed countries with extremely poor overall survival rate. In present study we set out epidemiological pattern with clinical profile of lung cancer patients in northern india population. Aim:We evaluate the effect of smoking with age distribution on histopathology in lung cancer patients. Material & Methods: We enrolled 218 patients after confirmation of histopathology and also collected demographic data. Results: Out of 218 patients of lung cancer, having median age of 56 years, we found 149 (68.3%) were smokers and 69 (31.6%) were nonsmokers. In histopathology 54.1% patients had squamous cell carcinoma, 29.2% adenocarcinoma, 12.4% Mixed cell, 3.7% Small cell. We also found 63.1% smoker to have squamous cell carcinoma and 50.7% non-smoker have adenocarcinoma.In our study middle age group patients were more frequent in smoking group. While higher age group patients has squamous cell and middle group have adenocarcinoma. Therefore patients group with high smoking are found to develop have more risk to develop small cell carcinoma rather than in case of non-smoker higher age groups have sqamous cell carcinoma type. Conclusion: In this study we found middle age group subjects of smoker having more squamous cell and nonsmoker having adenocarcinoma.
APA, Harvard, Vancouver, ISO, and other styles
2

Schouten, L. J., J. M. de Rijke, J. A. M. Huveneers, and A. L. M. Verbeek. "Rising incidence of breast cancer after completion of the first prevalent round of the breast cancer screening programme." Journal of Medical Screening 9, no. 3 (September 1, 2002): 120–24. http://dx.doi.org/10.1136/jms.9.3.120.

Full text
Abstract:
OBJECTIVES: After completion of the prevalent screening round of the breast cancer screening programme in Limburg, The Netherlands, incidences started rising once again. This increase was contrary to expectations, which had predicted a slightly higher, but stable, incidence after the first screening round. The trends in incidence were studied to find explanations for the observed rise in incidence. SETTING: Breast cancer screening programme in mid-Limburg and southern Limburg, the Netherlands. METHODS: The data files of the breast cancer screening programme and the Maastricht cancer registry were linked to evaluate the effect of breast cancer screening. Only the first primary breast tumour was included in the evaluation. RESULTS: The second peak of incidence after the prevalent screening round was 45% higher than the incidences before the start of the screening. Also, the decrease in incidence of large and node positive tumours was interrupted. Compared with national detection rates, the number of screen detected cancers was lower before 1995 and higher after that year. After 1997, incidence decreased again of all breast cancers, but also of large and node positive tumours. The incidence of node positive tumours showed large fluctuations, probably due to the introduction of the sentinel node procedure and immunohistochemistry. In 1999, incidence of large tumours and node positive tumours was 18% and 28%, respectively, lower than before the start of the screening. CONCLUSIONS: An increase in the background incidences and improved detection in the screening programme most likely explain this trend. The improved detection after 1995, and the lower than desirable decrease in large tumours, indicate that the screening performance was not optimal before 1996. The incidence of node positive tumours cannot be used any more as an indicator of the success of the screening programme because of detection bias.
APA, Harvard, Vancouver, ISO, and other styles
3

Ayman, Rasmy, Ameen Amal, and AbdMonem Amira. "Lung Cancer Treatment: Incidence and Survival: SEER Database." Cancer Medicine Journal 2, no. 2 (December 31, 2019): 36–40. http://dx.doi.org/10.46619/cmj.2019.2-1011.

Full text
Abstract:
Lung cancer is the most common cause of cancer death worldwide, with an estimated 1.6 million deaths each year. Nearly 85% of cases have a different histological groups jointly recognized as “Non-Small Cell Lung Cancer of which lung adenocarcinoma and lung squamous cell carcinoma are the most common subtypes”.
APA, Harvard, Vancouver, ISO, and other styles
4

Rahib, Lola, Mackenzie Wehner, Lynn McCormick Matrisian, and Kevin Thomas Nead. "Projection of cancer incidence and death to 2040 in the US: Impact of cancer screening and a changing demographic." Journal of Clinical Oncology 38, no. 15_suppl (May 20, 2020): 1566. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.1566.

Full text
Abstract:
1566 Background: Coping with the current and future burden of cancer requires an in-depth understanding of cancer incidence and death trends. As of 2020, breast, lung, prostate, and colorectal cancer are the most incident cancers, while lung, colorectal, pancreas, and breast cancer result in the most deaths. Here we integrate observed cancer statistics and trends with observed and estimated US demographic data to project cancer incidences and deaths to the year 2040. Methods: Demographic cancer-specific delay-adjusted incidence and death rates from the Surveillance, Epidemiology, and End Results Program (2014-2016) were combined with US Census Bureau population growth projections (2016) and average annual percentage changes in incidence (2011-2015) and death (2012-2016) rates to project cancer incidences and deaths through the year 2040. We examined the 10 most incident and deadly cancers as of 2020. We utilized Joinpoint analysis to examine changes in incidence and death rates over time relative to changes in screening guidelines. Results: We predict the most incident cancers in 2040 in the US will be breast (322,000 diagnoses in 2040) and lung (182,000 diagnoses in 2040) cancer. Continuing decades long observed incident rate trends we predict that melanoma (173,000 diagnoses in 2040) will become the 3rd most common cancer while prostate cancer (63,000 diagnoses in 2040) will become the 5th most common cancer after colorectal cancer (139,000 diagnoses in 2040). Lung cancer (61,000 deaths in 2040) is predicted to continue to be the leading cause of cancer related death, with pancreas (45,000 deaths in 2040) and liver & intrahepatic bile duct (38,000 deaths in 2040) cancer surpassing colorectal cancer (34,000 deaths in 2040) to become the second and third most common causes of cancer related death, respectively. Breast cancer deaths (29,000 in 2040) are predicted to continue to decrease and become the fifth most common cause of cancer death. Joinpoint analysis of incidence and death rates supports a significant past, present, and future impact of cancer screening programs on the number of cancer diagnoses and deaths, particularly for prostate, thyroid, melanoma incidences, and lung cancer deaths. Conclusions: We demonstrate marked changes in the predicted landscape of cancer incidence and deaths by 2040. Our analysis reveals an influence of cancer screening programs on the number of cancer diagnoses and deaths in future years. These projections are important to guide future research funding allocations, healthcare planning, and health policy efforts.
APA, Harvard, Vancouver, ISO, and other styles
5

Shetty, Priya B., Philip J. Lupo, and Michael E. Scheurer. "Abstract 5223: Pediatric cancer incidence among racial/ethnic groups living in rural/urban areas of the United States." Cancer Research 82, no. 12_Supplement (June 15, 2022): 5223. http://dx.doi.org/10.1158/1538-7445.am2022-5223.

Full text
Abstract:
Abstract Background: The impact of urban/rural residence on pediatric cancer incidence has not been well studied. Additionally, the impact of race/ethnicity on pediatric cancer incidence by urban/rural status has not been evaluated, which could inform our understanding of the roles of shared genetic and environmental causes of these malignancies. Methods: Using SEER18, we calculated pediatric cancer incidences for individuals diagnosed 2000-2018 by residence (urban/rural). Next we calculated incidence rate ratios (IRR) to evaluate the role of race/ethnicity on incidence stratified by urban vs. rural status. Results: See Table. Overall, most incidences were similar by residence, i.e., lower or equal in rural versus urban areas, except the rural group having significantly lower incidences of leukemias and germ cell tumors (GCTs). Additionally, the incidence of most pediatric cancers was consistently higher among NHW in both urban and rural areas. Yet, incidence of some cancers differed by urban/rural residence within race/ethnicity: retinoblastoma (NHB, Hispanic, and API); soft tissue sarcomas (NHB and AI/AN); hepatic tumors (AI/AN); and GCTs (API). Conclusions: In general, Hispanic, NHB, and AI/AN populations have similar incidence of pediatric cancers in urban or rural areas. These groups have some shared bio-geographical ancestry, suggesting a possible effect of genetics on risk. Further, differences in incidence by urban/rural residence within race/ethnicity suggest a possible role of environment for some cancers. Interestingly, for GCTs, NHB had a lower IRR in urban and rural areas, but Hispanic populations had a significantly higher IRR. This finding, consistent with a recent study in adults, suggest that African ancestry may confer a protective effect on risk of GCTs. Further, the GCT effect sizes were more protective in the rural group for each race/ethnicity group, suggesting the possible role of environmental factors and interactions of environment with ancestry. Pediatric cancer incidence by race/ethnicity group and urban/rural residence Citation Format: Priya B. Shetty, Philip J. Lupo, Michael E. Scheurer. Pediatric cancer incidence among racial/ethnic groups living in rural/urban areas of the United States [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr 5223.
APA, Harvard, Vancouver, ISO, and other styles
6

Yan, Kimberly L., Shanpeng Li, Chi-Hong Tseng, Jiyoon Kim, Dalena T. Nguyen, Nardeen B. Dawood, Masha J. Livhits, Michael W. Yeh, and Angela M. Leung. "Rising Incidence and Incidence-Based Mortality of Thyroid Cancer in California, 2000-2017." Journal of Clinical Endocrinology & Metabolism 105, no. 6 (March 13, 2020): 1770–77. http://dx.doi.org/10.1210/clinem/dgaa121.

Full text
Abstract:
Abstract Context The increased incidence of thyroid cancer globally over the past several decades is principally attributed to small, indolent papillary thyroid cancers. A possible concomitant increase in thyroid cancer-specific mortality remains debated. Objective The changes in thyroid cancer incidence and incidence-based mortality were assessed using a large population-based cohort over an 18-year period. Design & Patients A retrospective analysis of all thyroid cancers reported in the California Cancer Registry was performed (2000–2017). Age-adjusted incidence and incidence-based mortality rates were analyzed using a log-linear model to estimate annual percent change. Results We identified 69 684 individuals (76% female, median age 50 years) diagnosed with thyroid cancer. The incidence of thyroid cancer increased across all histological subtypes (papillary, follicular, medullary, and anaplastic) and all tumor sizes. The incidence increased from 6.43 to 11.13 per 100 000 person-years (average increase 4% per year; P < 0.001) over the study period. Thyroid cancer-specific mortality rates increased on average by 1.7% per year (P < 0.001). The increased mortality rates were greater in men (2.7% per year, P < 0.001) and patients with larger tumors (2-4 cm) (3.4% per year, P < 0.05). Conclusions Data from this statewide registry demonstrate that the incidence of thyroid cancer is increasing, and that this phenomenon is not restricted to small papillary thyroid cancers. Rising incidence in thyroid cancers of all sizes with concurrent increase of incidence-based mortality in men and those with larger tumors suggest a true increase in clinically significant disease.
APA, Harvard, Vancouver, ISO, and other styles
7

Abood, Rafid A., Kareem A. Abdahmed, and Seena S. Mazyed. "Epidemiology of Different Types of Cancers Reported in Basra, Iraq." Sultan Qaboos University Medical Journal [SQUMJ] 20, no. 3 (October 5, 2020): 295. http://dx.doi.org/10.18295/squmj.2020.20.03.008.

Full text
Abstract:
Objectives: This study aimed to report the incidence and pattern of various types of cancers and their distribution across various demographic groups in Basra, Iraq. Methods: Cancer cases recorded during 2017 at the Basra Cancer Control Centre, the Department of Pathology and Forensic Medicine, the Basra Oncology and Hematology Centre, the Basra Children’s Hospital and at private laboratories were included in the study. Patients’ records were analysed for information related to age, gender, residence and type of cancer. Incidences for different geographical regions and distribution of incidences across age groups were recorded as percentages. The mean age was recorded for patients of different genders and age groups. Incidence rates per 100,000 were calculated for different types of cancer. Results: A total of 2,163 cancer cases were identified of which 2,020 were in adults (93.4%) and 143 were in children (6.6%). Among adults, most cancers were found in females (59%). Patients’ mean age at diagnosis was 51.4 ± 19.6 years for adults and 6.4 ± 4.23 years for children. Cancer incidence rates per 100,000 people increased with age. Breast cancer was the most frequent cancer type found in adult females, with an incidence rate of 60.64 per 100,000 people. The most common types of cancer found in adult males were urinary bladder and lung and bronchus cancers; leukaemia was the most common cancer in children. Conclusion: The findings from this study can be used for predicting cancer epidemiology in Basra, Iraq, and to identify subsets of the population at high risk of cancer incidence. This information will help healthcare providers to adequately respond to the demands of diagnosis, treatment and palliative care for such patients.Keywords: Neoplasms; Incidence; Epidemiology; Demography; Iraq.
APA, Harvard, Vancouver, ISO, and other styles
8

Rohatgi, Atharva, Cheng-I. Liao, Michelle Ann Caesar, Caitlin Ruth Johnson, Joshua Elbridge Chan, Daniel Stuart Kapp, and John K. Chan. "The increasing incidence of alcohol-related cancers in young adults in the United States: Who is most at risk?" Journal of Clinical Oncology 40, no. 16_suppl (June 1, 2022): 10563. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.10563.

Full text
Abstract:
10563 Background: To evaluate incidences and trends of alcohol-associated cancers in United States adults over the last 18 years. Methods: Data was extracted from the United States Cancer Statistics database from 2001 to 2018. SEER*Stat Joinpoint Regression program 4.8.1 was used to calculate incidences and trends. Average annual percentage change (AAPC) was used to describe trends. Based on the ICD-O-3 criteria, liver, colon, oral cavity, esophagus, and pharynx cancers were classified as alcohol-related cancers. Results: Over the last 18 years, the incidence of alcohol-associated cancers decreased overall in males and females by 0.9% every year (p < 0.001). Alcohol-associated cancers increased significantly in younger patients under the age of 39 years old (p < 0.001). Based on race, Black men and women had the highest incidence at 135.17/100,000 followed by 132.50 in White individuals, 105.84 in Hispanic individuals, and 104.28 in Asian individuals. By region, the incidence was found to be the highest in the Midwest at 132.89/100,000 and lowest in the West at 120.33. Based on cancer types, the most common alcohol related cancer was colorectal cancer with an incidence at 36.49/100,000 in 2018, followed by oral cavity cancers at 11.69, liver cancer at 6.76, esophagus cancer at 4.51, and larynx cancer at 2.92. Of all these types of cancers, liver cancer had the highest annual increase at 2.43% (p < 0.001). Using a projection model, we found that liver cancer is estimated to surpass colorectal cancer by the year 2035. On intersectionality analysis, White men and women in the Northeast between the ages of 75-79 had the highest incidence of alcohol-associated cancers at 584.10/100,000 in 2018. However, over the last 18 years, White men and women in the South between the ages of 20-24 had the highest annual increase at 4.08% (p < 0.001). Conclusions: Over the last 18 years, alcohol-related cancers increased in the younger patients, particularly those residing in the South. Liver cancer is increasing at the highest rate.
APA, Harvard, Vancouver, ISO, and other styles
9

Bukya, Sheela. "Colorectal Cancer Incidence in Tertiary Health Care Centre-Hyderabad." Indian Journal of Cancer Education and Research 5, no. 2 (2017): 109–12. http://dx.doi.org/10.21088/ijcer.2321.9815.5217.9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Hemminki, Kari, Jan Sundquist, and Andreas Brandt. "Familial Mortality and Familial Incidence in Cancer." Journal of Clinical Oncology 29, no. 6 (February 20, 2011): 712–18. http://dx.doi.org/10.1200/jco.2010.30.5664.

Full text
Abstract:
Purpose An overwhelming majority of data on familial risk in cancer is based on incident cancer, whereas familiality in cancer mortality is largely unknown. If fatal form of cancer was a highly familial subtype, then familial risk for mortality may exceed that of incidence, which would be particularly relevant for clinical decision making and counseling. Patients and Methods The individuals in the nationwide Swedish Family-Cancer Database were classified according to family history of fatal and nonfatal cancer. Familial risks of incident and fatal concordant cancer were calculated for offspring based on their parental family history using a Cox model with hazard ratio (HR); offspring without family history were the reference. Results Most HRs for offspring incident cancers were somewhat higher for fatal compared with nonfatal parental family history. For breast (HR, 1.87 fatal v 1.66 nonfatal; P < .001) and prostate (HR, 2.30 fatal v 1.84 nonfatal; P < .001) cancers, 51.0% of patients with familial breast cancer and 56.6% of patients with prostate cancer had fatal family history. HRs for death in offspring according to a fatal compared with nonfatal family history were significantly increased for colorectal (HR, 1.76 v 1.47, respectively; P = .02), breast (HR, 1.97 v 1.51, respectively; P = .002), and prostate (HR, 2.03 v 1.59, respectively; P = .002) cancers. TNM classification did not seem to differ between the family histories. We showed also that an overwhelming proportion of offspring were diagnosed after the parental death. Conclusion Familial breast, prostate, and colorectal cancers might have a yet unidentified genetic component associated with poorer survival. It may be useful to record survival data in family history records.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Cancer incidence"

1

Hornsby, C. "The population incidence of cancer." Thesis, University College London (University of London), 2009. http://discovery.ucl.ac.uk/14896/.

Full text
Abstract:
In this thesis stochastic techniques are used in attempts to understand cancer risk, its relationship to patient age and genotype, as well as its distribution in human populations. The starting point for the thesis is the general observation that cancer incidence grows in approximate proportion to an integer power of age. Quasi-mechanistic mathematical models of cancer incidence have suggested that the integer power in a given case is related to the number of crucial cellular events that must occur for a malignant tumour to evolve from a healthy tissue. This idea and its limitations are explored. Further applications of cancer incidence models are then evaluated and developed. Specifically, a critical examination is presented of the notion that increases in risk associated with a particular predisposing germline gene mutation, can provide information about the disease-associated activity of that gene. Finally, there is a discussion of heterogeneity in liability to cancer. Methods for quantifying this heterogeneity and its effect on incidence patterns are investigated.
APA, Harvard, Vancouver, ISO, and other styles
2

Jégu, Jérémie. "Cancer ultérieur chez les survivants d'un premier cancer : incidence et impact sur la survie." Thesis, Strasbourg, 2014. http://www.theses.fr/2014STRAJ006/document.

Full text
Abstract:
Les objectifs de cette thèse étaient d’étudier les tendances du risque de second cancer primitif (SPC) selon l’année de diagnostic d’un premier cancer des voies aéro-digestives supérieures (VADS) dans le Bas-Rhin, de produire les premières estimations de l’incidence des SPC à l’échelle nationale en France et d’estimer la survie des patients atteints d’un cancer des VADS selon la présence d’antécédents de cancer. Ce travail a montré que : 1) L’excès de risque de SPC des VADS et de l’œsophage a diminué de 53% entre 1975 et 2006 dans le Bas-Rhin, mais que le risque de SPC du poumon est resté stable ; 2) Le risque de SPC en France est augmenté de 36% chez les patients atteints de cancer par rapport à la population générale ; 3) La survie des hommes atteints d’un cancer des VADS était fortement associée à la présence d’antécédents de cancer. Des perspectives se dégagent de ce travail en termes de recherche épidémiologique, de recherche clinique et de politiques de santé publique
The objectives of this PhD thesis were: to study the trends of the risk of second primary cancer (SPC) among patients with a head and neck (HNSCC) cancer in Bas-Rhin, to provide first nationwide estimates of the risk of SPC in France and to assess the survival of patients with a HNSCC depending on their history of cancer. This work showed that : 1) The excess risk of SPC of head and neck and esophagus sites decreased by 53% over three decades among patients with a HNSCC, and that the excess risk of SPC of the lung did not change significantly. 2) The risk of SPC among cancer survivors in France was increased by 36% compared to the general population. 3) History of cancer was strongly associated with survival among HNSCC patients. Several epidemiological and clinical research perspectives can be established based on this work. These results also present an interest in a public health perspective in the framework of the third cancer plan
APA, Harvard, Vancouver, ISO, and other styles
3

Lepage, Côme. "Epidémiologie des cancers digestifs rares : incidence, tendances chronologiques, pronostic." Dijon, 2007. http://www.theses.fr/2007DIJOMU01.

Full text
Abstract:
L’objectif principal de ce travail était d’améliorer les connaissances épidémiologiques des tumeurs digestives rares jusqu’alors parcellaires puisque essentiellement basées sur des données hospitalières. Nous avons pu montrer qu’à l’image des autres cancers digestifs, leur incidence est en constante augmentation, et concernant adénocarcinomes de l’oesophage que cette hausse était en passe de devenir préoccupante. Ce travail réunit des données épidémiologiques sur les cancers digestifs rares à partir de bases de population qui pour la plupart étaient inexistantes. Ces données sont précieuses pour estimer la prise en charge médicale ou les besoins de surveillance de ces cancers, pour concevoir et analyser des enquêtes à visée étiologique, définir une politique de prévention et éventuellement de dépistage. Nous avons pu prouver que les données de registres avaient non seulement un intérêt dans l’étude des caractéristiques épidémiologiques des tumeurs digestives rares, mais qu’elles étaient incontournables
Important changes have occurred in the epidemiology of rare digestive cancers. It is difficult to obtain unbiased data to study the epidemiology of those cancers. Population-based studies recording all cases in a well-defined population represent the only way to assess this disquieting situation. Thus the objective of this study was to examine trends in incidence prognosis and socio economical disparities to improve the epidemiological knowledge of these cancers. The prognosis in the general population is considerably worse than is often reported from small hospital case series. Early diagnosis is difficult: new therapeutic options appear to represent the best approach to improved prognosis. All cancers were characterised by a sharp increase of incidence over the past years, both by period and birth cohort, but the most important rise was for oesophageal adenocarcinoma. Etiological studies still necessary to understand the reasons of such a rise
APA, Harvard, Vancouver, ISO, and other styles
4

Seigneurin, Arnaud. "Evaluation du dépistage du cancer du sein par mammographie : estimation du surdiagnostic, de la participation des femmes après un résultat faux positifs et de l'incidence des cancers de l'intervalle." Phd thesis, Université de Grenoble, 2011. http://tel.archives-ouvertes.fr/tel-00637175.

Full text
Abstract:
L'intérêt du programme de dépistage du cancer du sein par mammographie résulte de la balance entre la réduction de la mortalité et les effets indésirables du programme. L'objectif de ce travail était d'évaluer trois aspects du programme de dépistage dans le département de l'Isère. Nous avons utilisé une méthode Approximate Bayesian Computation pour estimer le surdiagnostic lié au dépistage par mammographie de cancers non évolutifs. Ils représentaient respectivement 1,5% (IC95% : 0,3% - 2,9%) et 28,0% (IC95% : 2,2% - 59,8%) des cancers invasifs et in situ diagnostiqués. Nous avons réalisé une revue de la littérature des méthodes d'estimation du surdiagnostic et montré sur des données simulées que les méthodes basées sur les taux d'incidence annuels étaient les moins sensibles aux biais. Par ailleurs, l'incidence des cancers de l'intervalle était inférieure lorsque les mammographies étaient réalisées avec deux clichés par sein au lieu d'un seul, aussi bien à 12 que à 24 mois. Enfin, l'exclusion du diagnostic de cancer après la réalisation d'une imagerie supplémentaire, d'une biopsie ou un suivi radiologique diminuait la participation lors de la prochaine invitation au dépistage organisé. En conclusion, l'intérêt du programme de dépistage du cancer du sein par mammographie n'est pas remis en cause avec 1,4 décès évité pour un cancer surdiagnostiqué (in situ ou invasif).
APA, Harvard, Vancouver, ISO, and other styles
5

Burrus, Kimberly J. "Cancer incidence by immigrant status in British Columbia." Thesis, University of British Columbia, 2015. http://hdl.handle.net/2429/54683.

Full text
Abstract:
Introduction: Cancer differentially affects populations and geographical regions. Given the ethnic diversity and growing population of immigrants in Canada and British Columbia in particular, it is important to understand how the risk of cancer is distributed according to where in BC immigrants live, given that this population may experience distinct cancer risks. Objectives: The purpose of this study is to understand how cancer incidence rates in BC vary by the regional proportion of immigrants and to explore how these rates are associated with duration of residence (recent versus well established), age at immigration, and country of origin. Methods: Analyses were conducted using a dataset of adult incident cancers diagnosed in BC (2000 to 2009) collected by the BC Cancer Registry. Regional-level estimates of the proportion of immigrants, as well as the socioeconomic and ethnic profiles of the BC population, were obtained from the Statistics Canada 2006 Census (defined by Local Health Area) and linked to the Cancer Registry data. Poisson and Negative Binomial regression models were used to estimate the rate ratios (RR) of cancer incidence by proportion of immigrants. Results: Overall, regional immigrant density significantly predicted lower cancer incidence rates for all-cancers and the most common cancers of the breast, prostate, colon and lung. However, for less common cancers of the liver, stomach and pharynx, proportion of immigrants significantly predicted higher cancer risk. This association was seen for recent and established immigrants, although cancer rates were higher among established immigrants. The proportion of immigrants at a younger age at immigration and from European origin were associated with increased risk for all-cancers and common cancers, but decreased risk of less common cancers. The proportion of immigrants at an older age at arrival (particularly 45 years and older) and from Asian origin were associated with decreased all-cancer risk and the risk of common cancers, but increased risk of less common cancers. Conclusion: Regional-level concentration of immigrants predicted cancer incidence rates in BC. Regional data on cancer incidence is important for developing effective health promotion strategies and public health planning by various Local Health Areas and health authorities in BC.
Medicine, Faculty of
Population and Public Health (SPPH), School of
Graduate
APA, Harvard, Vancouver, ISO, and other styles
6

Fink, Brian N. Gammon Marilie D. "Flavonoid intake and breast cancer incidence and survival." Chapel Hill, N.C. : University of North Carolina at Chapel Hill, 2006. http://dc.lib.unc.edu/u?/etd,1280.

Full text
Abstract:
Thesis (Ph. D.)--University of North Carolina at Chapel Hill, 2006.
Title from electronic title page (viewed Oct. 10, 2007). "... in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Department of Epidemiology, School of Public Health." Discipline: Epidemiology; Department/School: Public Health.
APA, Harvard, Vancouver, ISO, and other styles
7

Kim, Yo-Eun. "Geography of colo-rectal cancer : incidence and survival." Thesis, Lancaster University, 1999. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.287101.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Smith, Sarah Jane. "Cancer in Trent region : incidence, mortality and survival." Thesis, University of Nottingham, 1999. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.312199.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Bedford, Ronald L. Field R. William. "Utility of death certificate data in predicting cancer incidence." [Iowa City, Iowa] : University of Iowa, 2009. http://ir.uiowa.edu/etd/336.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Pham, Tu Lan. "Incidence des cancers dans les thromboses veineuses." Montpellier 1, 1996. http://www.theses.fr/1996MON11068.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Cancer incidence"

1

Canada. Health Canada. Working Group on Geographic Surveillance. Canadian cancer incidence atlas: Vol. 1, Canadian cancer incidence. Ottawa: Health Canada., 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

M, Parkin D., and International Agency for Research on Cancer., eds. International incidence of childhood cancer. Lyon: International Agency for Research on Cancer, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

M, Parkin D., and International Agency for Research on Cancer., eds. International incidence of childhood cancer. Lyon: International Agency for Research on Cancer, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Carvalho, Manoel Ricardo da Costa., Franco Eduardo Luiz Fabiano, and Ludwig Institute for Cancer Research., eds. Cancer incidence in Recife County, Brazil. [São Paulo]: Recife Cancer Registry, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Gaudette, Leslie A. Cancer incidence in Canada, 1969-1993. Ottawa, Ont: Statistics Canada, Health Statistics Division, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

P, Coleman Michel, International Agency for Research on Cancer., International Union against Cancer, and International Association of Cancer Registries., eds. Trends in cancer incidence and mortality. Lyon: International Agency for Research on Cancer, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Richard, Doll, Fraumeni Joseph F, and Muir C. S, eds. Trends in cancer incidence and mortality. Plainview, N.Y: Cold Spring Harbor Laboratory Press, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Kohler, Betsy A. Cancer incidence in New Jersey, 1992-1996. Trenton, New Jersey (P.O. Box 369 Trenton 08625-0369): New Jersey State Department of Health and Senior Services, Office of Cancer Epidemiology, State Cancer Registry, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Frank, Steven A. Dynamics of cancer: Incidence, inheritance, and evolution. Princeton, NJ: Princeton University Press, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Qiao, Baozhen. Illinois cancer statistics review incidence, 1998 - 2002. Springfield, IL: Illinois Department of Health, Division of Epidemiologic Studies, Illinois State Cancer Registry, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Cancer incidence"

1

Ayash, Claudia. "Cancer Incidence." In Encyclopedia of Immigrant Health, 347–48. New York, NY: Springer New York, 2012. http://dx.doi.org/10.1007/978-1-4419-5659-0_114.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Tanaka, Koji, Toshimitsu Araki, Yuji Toiyama, Yoshiki Okita, Yasuhiko Mohri, and Masato Kusunoki. "Incidence and Risk Factors." In Colitis-Associated Cancer, 23–39. Tokyo: Springer Japan, 2016. http://dx.doi.org/10.1007/978-4-431-55522-3_2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Kemp, I. "Scottish Cancer Incidence Atlas 1985." In Cancer Mapping, 137–42. Berlin, Heidelberg: Springer Berlin Heidelberg, 1989. http://dx.doi.org/10.1007/978-3-642-83651-0_14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Hardcastle, Jack Donald. "Trends in Incidence and Mortality." In Colorectal Cancer, 3–4. Berlin, Heidelberg: Springer Berlin Heidelberg, 1993. http://dx.doi.org/10.1007/978-3-642-78225-1_2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Ramirez, Amelie G., Ian M. Thompson, and Leonel Vela. "Cancer Incidence and Mortality." In The South Texas Health Status Review, 33–56. Cham: Springer International Publishing, 2013. http://dx.doi.org/10.1007/978-3-319-00233-0_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Robin, Peter E., Jean Powell, Guy M. Holme, John A. H. Waterhouse, Christopher C. McConkey, and Janet E. Robertson. "Incidence by Sub-site." In Cancer of the Larynx, 61–79. London: Palgrave Macmillan UK, 1989. http://dx.doi.org/10.1007/978-1-349-10418-5_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Goodman, Marc T. "Cancer Incidence Among Asian-Americans." In Minorities and Cancer, 35–44. New York, NY: Springer New York, 1989. http://dx.doi.org/10.1007/978-1-4612-3630-6_3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Zycinska, Katarzyna, Jolanta Kostrzewa-Janicka, Aneta Nitsch-Osuch, and Kazimierz Wardyn. "Cancer Incidence in Pulmonary Vasculitis." In Neurobiology of Respiration, 349–53. Dordrecht: Springer Netherlands, 2013. http://dx.doi.org/10.1007/978-94-007-6627-3_47.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Haymart, Megan R., and Nazanene H. Esfandiari. "Incidence and Epidemiology." In Management of Thyroid Nodules and Differentiated Thyroid Cancer, 1–10. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-43618-0_1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Gatta, Gemma. "Epidemiological Aspects in Nasopharyngeal Cancer." In Critical Issues in Head and Neck Oncology, 319–25. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-63234-2_21.

Full text
Abstract:
AbstractNasopharyngeal cancer (NPC) is an uncommon cancer. According to the Global Cancer Observatory, of the 129,000 new diagnoses in 2018, 85% has been made in the Asiatic population. In males the annual age adjusted rate of incidence (per 100,000) dramatically varied between 8 in South-Eastern Asia and <1 in Europe. In Europe (period of diagnosis 1999–2007), the annual incidence rate varied between 0.7 (South of Europe) and 0.2 (North of Europe). Incidence is three time higher in men than women. Elderly are more affected than young people. Five-year survival, from European population based cancer registries was 49% (period 1999–2007), survival was better in younger than in older patients (73% vs. 31%), prognosis was more favorable in women than men (54% vs. 47%). Geographical variation of survival was reported, with poor 5-year in the Eastern European countries (36%).Incidence and population based survival are crucial for public health and planning clinical study. Lifestyle and environmental factors are responsible of the decreasing trend of incidence in quite all the world countries.Being one of the rare diseases, NPC need to be centralized for diagnosis and treatment. In Europe, the European Joint Action of Rare Cancers and the European Reference Network for rare disease will play an important role to make progress and reduce geographical disparities.
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Cancer incidence"

1

Bravos, Elodie, Vincent Cottin, Claire Dauphin, Hélène Bouvaist, Julie Traclet, Romain Trésorier, Souad Bezzeghoud, et al. "Cancer incidence in incident patients with precapillary pulmonary hypertension." In ERS International Congress 2018 abstracts. European Respiratory Society, 2018. http://dx.doi.org/10.1183/13993003.congress-2018.pa3088.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Kim, Min Kyu, Soo Youn Bae, and Jee Yeon Lee. "Abstract 1303: Genetic cancer incidence." In Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA. American Association for Cancer Research, 2014. http://dx.doi.org/10.1158/1538-7445.am2014-1303.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Ai, Xu Xin, Hu Jia, and Lu Xin. "SVM-based Cancer Incidence Forecasting of Patients." In 2016 9th International Symposium on Computational Intelligence and Design (ISCID). IEEE, 2016. http://dx.doi.org/10.1109/iscid.2016.2074.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Aksenenko, O. S. "INCIDENCE AND PREVENTION OF LUNG CANCER IN THE REPUBLIC OF BELARUS." In SAKHAROV READINGS 2021: ENVIRONMENTAL PROBLEMS OF THE XXI CENTURY. International Sakharov Environmental Institute of Belarusian State University, 2021. http://dx.doi.org/10.46646/sakh-2021-2-10-13.

Full text
Abstract:
A statistical analysis of the incidence of lung cancer in the period from 2013-2019 and the prevention of lung cancer was carried out. The databases of the Minsk City Clinical Oncology Dispensary were studied and analyzed for 2013, 2014, 2015, 2016, 2017, 2018, 2019 years.
APA, Harvard, Vancouver, ISO, and other styles
5

Xie, Jingyi. "Suggested Modification of Previous Published Log-Incidence Mathematical Model of Breast Cancer Incidence." In 2021 International Conference on Public Art and Human Development ( ICPAHD 2021). Paris, France: Atlantis Press, 2022. http://dx.doi.org/10.2991/assehr.k.220110.058.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Chaudhary, Sushila. "Successful pregnancy outcome in recurrent ovarian cancer." In 16th Annual International Conference RGCON. Thieme Medical and Scientific Publishers Private Ltd., 2016. http://dx.doi.org/10.1055/s-0039-1685320.

Full text
Abstract:
Incidences of ovarian cancer in pregnancy are increasing nowadays due to routine use of ultrasonography in first trimester and postponement of childbirth to an older age. Reported incidence of ovarian tumor in pregnancy is 1:1000 among them3.6% are malignant. We report a case of recurrent ovarian tumor with successful pregnancy outcome. She was a 26 yr old primi had ovarian cancer recurrence 2 year after primary surgery. In present pregnancy she was given chemotherapy with two doses of carboplatin, and had viable baby at 34 weeks of pregnancy. At present mother and baby are doing well and on regular follow-up at radiotherapy departments.
APA, Harvard, Vancouver, ISO, and other styles
7

Garcia-Uribe, Alejandro, Karthik C. Balareddy, Jun Zou, Kenneth K. Wang, Madeleine Duvic, and Lihong V. Wang. "Epithelial cancer detection by oblique-incidence optical spectroscopy." In SPIE BiOS: Biomedical Optics, edited by Anita Mahadevan-Jansen, Tuan Vo-Dinh, and Warren S. Grundfest. SPIE, 2009. http://dx.doi.org/10.1117/12.808576.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Lee, Kyoungho, Joohee Han, Kwansick Kim, and Soo-Geun Kim. "Abstract 125: Hematological cancer incidence among semiconductor workers." In Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1538-7445.am2013-125.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Poroshenko, Anatoly. "DISSYMMETRY OF KIDNEY CANCER INCIDENCE as PREDICTIVE FACTOR." In XVIII INTERNATIONAL INTERDISCIPLINARY CONGRESS NEUROSCIENCE FOR MEDICINE AND PSYCHOLOGY. LCC MAKS Press, 2022. http://dx.doi.org/10.29003/m2895.sudak.ns2022-18/275-276.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Vargas-Castanho, Margarida Souto, Sara Cerqueira, Marta Sousa, Marta Gomes, Rita Gaio, and Raquel Duarte. "Lung cancer and TB incidence evolution in Portugal." In ERS International Congress 2018 abstracts. European Respiratory Society, 2018. http://dx.doi.org/10.1183/13993003.congress-2018.pa2720.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Cancer incidence"

1

McCaig, Fiona, and Jonathon Olsburgh. Urological cancer incidence in renal transplant recipients. BJUI Knowledge, November 2022. http://dx.doi.org/10.18591/bjuik.0375.v2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Athas, W. F. Investigation of excess thyroid cancer incidence in Los Alamos County. Office of Scientific and Technical Information (OSTI), April 1996. http://dx.doi.org/10.2172/548910.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Lopez, Joseph A. A Comparison of Prostate Cancer Incidence Between U.S. Air Force Enlisted Aircrew. Fort Belvoir, VA: Defense Technical Information Center, June 2011. http://dx.doi.org/10.21236/ada561476.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Walker, Christopher. Incidence of Testicular Cancer in U.S. Air Force Officer Aviators: 1998-2008. Fort Belvoir, VA: Defense Technical Information Center, June 2011. http://dx.doi.org/10.21236/ada554672.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Wang, Yan, Wenpeng Song, Sicheng Zhou, Jie Tian, Yingxian Dong, Jue Li, Junke Chang, et al. Increased risk for subsequent primary lung cancer among female hormone-related cancer patients: a meta-analysis based on over four million cases. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, July 2022. http://dx.doi.org/10.37766/inplasy2022.7.0044.

Full text
Abstract:
Review question / Objective: To identify the risk of lung cancer in FHRC patients compared to the general population. Condition being studied: The incidence rate of lung cancer in women is obviously increasing over the past decade and previous evidence have indicated the significant relationship between disturbances in hormone levels and the risk of lung cancer. Therefore, we hypothesized female hormone-related cancer (FHRC), including the breast, endometrial, cervix, and ovary cancer, patients may experience a higher risk of developing subsequent lung cancer.
APA, Harvard, Vancouver, ISO, and other styles
6

Yambo-Arias, Ramon. Incidence of Testicular Cancer in U.S. Air Force Active Duty Enlisted Male Aircrew. Fort Belvoir, VA: Defense Technical Information Center, June 2011. http://dx.doi.org/10.21236/ada547195.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Bubley, Glenn. Effect of a HIF-1 Alpha Polymorphism on the Incidence and Prostate Cancer. Fort Belvoir, VA: Defense Technical Information Center, February 2007. http://dx.doi.org/10.21236/ada470130.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Bubley, Glen. Effect of a HIF-1 Alpha Polymorphism on the Incidence and Prostate Cancer. Fort Belvoir, VA: Defense Technical Information Center, February 2008. http://dx.doi.org/10.21236/ada482311.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Day, Agnes A., John Stubbs, Rina Das, and Marti Jett. Breast Cancer in African American Women: Molecular Analysis of Differences in Incidence and Outcomes. Fort Belvoir, VA: Defense Technical Information Center, October 2005. http://dx.doi.org/10.21236/ada450406.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Gilles, Floyd H., Eugene Sobel, and Zoreh Davanipour. Low Melatonin Production During Adulthood: A Possible Genetic Susceptibility Factor for Breast Cancer Incidence. Fort Belvoir, VA: Defense Technical Information Center, October 2002. http://dx.doi.org/10.21236/ada412881.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Cancer incidence' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography